Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MDM4 | O15151 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22686111 | 0.84 | GABRA1 (0.44) | GABRA1GABRB2CA1CA2CYP3A4 | |
| SCHEMBL7124077 | 0.81 | ROCK2 (0.39) | FABP3FABP4FABP5ROCK2GABRA1 | |
| SCHEMBL30317598 | 0.81 | ROCK2 (0.39) | FABP3FABP4FABP5ROCK2GABRA1 | |
| SCHEMBL16050488 | 0.81 | GABRA1 (0.52) | FABP3FABP4FABP5ROCK2GABRA1 | |
| SCHEMBL14950367 | 0.80 | ROCK2 (0.37) | FABP3FABP4FABP5ROCK2GABRA1 | |
| Hydrochloric Acid SCHEMBL21331878 | 0.79 | ROCK2 (0.38) | FABP3FABP4FABP5ROCK2GABRA1 | |
| Lithium Ion SCHEMBL17203679 | 0.79 | ROCK2 (0.38) | FABP3FABP4FABP5ROCK2GABRA1 | |
| SCHEMBL28126975 | 0.79 | GABRA1 (0.50) | FABP3FABP4FABP5ROCK2GABRA1 | |
| SCHEMBL14931037 | 0.78 | HDAC4 (0.39) | FABP3FABP4FABP5ROCK2GABRA1 | |
| SCHEMBL28438073 | 0.77 | GABRA1 (0.38) | FABP3FABP4FABP5ROCK2GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3749674-A1 | MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-12-16 | — | — | EP | claimed |
| US-20200369697-A1 | MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2020-11-26 | — | — | US | claimed |
| EP-3662996-A2 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | Verbio Vereinigte BioEnergie AG (DE) | 2020-06-10 | — | — | EP | claimed |
| WO-2019157376-A1 | MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-08-15 | — | — | WO | claimed |
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | XIMO AG (CH) | 2019-07-09 | — | — | US | claimed |
| US-20160030936-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2016-02-04 | — | — | US | claimed |
| EP-2969204-A2 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XiMo AG (CH) | 2016-01-20 | — | — | EP | claimed |
| US-20140309466-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2014-10-16 | — | — | US | claimed |
| WO-2014139679-A2 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XIMO AG (CH) | 2014-09-18 | — | — | WO | claimed |
| EP-3269750-B1 | SYNDIOTACTIC CRYSTALLINE DICYCLOPENTADIENE RING-OPENING POLYMER HYDRIDE | ZEON CORP (JP) | 2023-10-18 | — | — | EP | disclosed |
| US-11779911-B2 | Production of fatty olefin derivatives via olefin metathesis | PROVIVI, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| EP-4234522-A2 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | Provivi, Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-3269751-B1 | SYNDIOTACTIC CRYSTALLINE DICYCLOPENTADIENE RING-OPENING POLYMER HYDRIDE, SYNDIOTACTIC DICYCLOPENTADIENE RING-OPENING POLYMER, AND PRODUCTION METHOD FOR THESE | ZEON CORP (JP) | 2023-08-09 | — | — | EP | disclosed |
| EP-3377465-B1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | PROVIVI INC (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2016143911-A1 | HYDROGENATED SYNDIOTACTIC NORBORNENE-BASED RING-OPENING POLYMER | ZEON CORPORATION (JP) | 2016-09-15 | — | — | WO | disclosed |
| US-20160264721-A1 | HYDROGENATED SYNDIOTACTIC NORBORNENE-BASED RING-OPENING POLYMER | ZEON CORPORATION (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20160030936-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2016-02-04 | — | — | US | disclosed |
| EP-2969204-A2 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XiMo AG (CH) | 2016-01-20 | — | — | EP | disclosed |
| US-20140309466-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2014-10-16 | — | — | US | disclosed |
| WO-2014139679-A2 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XIMO AG (CH) | 2014-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | MSMO1, SQLE, MOGAT2 | FABP3 4506/4885FABP4 3688/4885FABP5 4156/4885 |
| US-20200369697-A1 | MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS | MSRB3, MMAB, CYB5R3 | FABP3 4811/4885FABP4 4632/4885FABP5 4432/4885 |
| US-20140309466-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | MSMO1, PYM1, SQLE | FABP3 4865/4885FABP4 4838/4885FABP5 4860/4885 |
| US-20160030936-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | MSMO1, SQLE, PYM1 | FABP3 4872/4885FABP4 4843/4885FABP5 4862/4885 |
| US-11779911-B2 | Production of fatty olefin derivatives via olefin metathesis | SREBF1, F2, SREBF2 | FABP3 1644/4885FABP4 106/4885FABP5 259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.